Ê÷ͻ״ϸ°û
ÏÈÌìÃâÒߺÍ˳ӦÐÔÃâÒßÖ®¼äµÄÇÅÁº
2011ÄêµÄŵ±´¶ûÉúÒ½½±µÃÖ÷ʷ̹Âü£¬·¢Ã÷Ê÷ͻ״ϸ°û£¨DC£©ÊÇÈËÀàÃâÒßϸ°ûϵͳµÄ˾Áî¹Ù£¬ÏÂÁîÖ÷µ¼ÃâÒßϵͳµÄÖÖÖÖ¹¦Ð§¡£DCµÄ¹¦Ð§ÊÇÍÌÊÉ¡¢¼Ó¹¤¼°³ÊµÝ¿¹Ô£¬½«½»ÊÖ¹ýµÄ°©Ï¸°ûÌØÕ÷¸æË߸¨ÖúTϸ°ûºÍBϸ°û¡£½ÓÊÜÊ÷Í»DCϸ°ûÖ¸ÁîµÄ¸¨ÖúTϸ°û£¬»á»î»¯Ï¸°û¶¾ÐÔTϸ°û¡¢×ÔȻɱÊÖNKϸ°û¡¢¾ÞÊÉϸ°ûºÍÒѾ½ÓÊÜÊ÷Í»DCϸ°û´Ì¼¤µÄBϸ°û£»Ï¸°û¶¾ÐÔTϸ°û»áÔÚ±æʶ°©Ï¸°ûºóÓèÒÔð²É±£¬ÉÙÊýµÄϸ°û¶¾ÐÔTϸ°û»á±»¸¨ÖúTϸ°ûתΪӰÏóTϸ°û£»×ÔȻɱÊÖNKϸ°û»áÖ±½Ó¹¥»÷°©Ï¸°û£¬¾ÞÊÉϸ°ûÔò»á¸üÈÝÒ×ÆÊÎöËùÍÌÊɵݩϸ°û¡£
Fig.1 A dendritic cell (blue) engages a T cell (yellow).
DC×÷ΪÏÖÔÚ¹«ÈϵÄ×îÓÐÓõĿ¹Ô³ÊµÝϸ°û,Ôڽ鵼¹ÌÓÐÃâÒßÓ¦´ðºÍÓÕµ¼Ë³Ó¦ÐÔÃâÒßÓ¦´ðÖÐÆðÒªº¦×÷Ó㬿ÉÒÔÓÕµ¼Ö×ÁöÃâÒßÄÍÊÜ¡£»ùÓÚDCµÄÃâÒßÁÆ·¨ÊÇʹÓû¼Õß×ÔÉíÃâÒßϵͳµÄDZÁ¦Ïû³ýתÒÆÐÔ¡¢ÄÑÖÎÐÔ¶ñÐÔÖ×ÁöÖеÄÖ×Áöϸ°û¡£Ðí¶àDCÒßÃçÒѾÙÐÐÁËÁÙ´²²âÊÔ,ÇÒ¾ßÓÐÃâÒßÔÐÔ£¬ÔÚijЩÇéÐÎÏÂÓëÁÙ´²Ð§¹ûÏà¹Ø¡£ÒÔDCΪ»ù´¡µÄÖ×ÁöÃâÒßÖÎÁÆÏà¹ØµÄÁÙ´²Ñо¿ÔÚº£ÄÚÍâÒ»Ö±¿ªÕ¹£¬ÌåÏÖÁËÖ×ÁöÃâÒßÖÎÁÆÔÚ¶ñÐÔÖ×ÁöÖÎÁÆÖеÄÇ¿Ê¢ÓÅÊÆ¡£
DCÊôÓÚµ¥ºËÍÌÊÉϸ°û£¨mononuclear phagocytes £¬MPs£©£¬MPs°üÀ¨¾ÞÊÉϸ°û£¬µ¥ºËϸ°û£¬Ê÷ͻ״ϸ°û¡£Ê÷ͻ״ϸ°û£¨DC£©µÄÑÇȺ¾ßÓвî±ðµÄ·¢ÓýÌØÕ÷£¬×¨ÃÅÓÃÓÚÆô¶¯²î±ðÀàÐ͵ÄЧӦTϸ°û£¬´Ó¶øµ÷½âÃâÒß·´Ó¦µÄЧ¹û¡£×î³õ£¬Ê÷ͻ״ϸ°û±»·ÖΪÁܰͺÍËèϵÁ½À࣬µ«ÕâÒ»ÃüÃûÒªÁì²¢²»¿É׼ȷ·´Ó¦Ã¿¸öÊ÷ͻ״ϸ°ûÑÇȺµÄ·¢ÓýÆðÔ´¡£Æ¾Ö¤ÈªÔ´ºÍ·Ö½â;¾¶¿ÉÒÔ½«Ê÷ͻ״ϸ°û·ÖΪ¹Å°åDCs£¨conventional DCs,cDCs£©£¬Ñª½¬DCs£¨plasmacytoid DCs,pDCs£©£¬ÀʸñººË¹Ï¸°û£¨Langerhans cells,LCs£©¡£cDCsÓÖ·ÖΪ¹Å°åIÐÍÊ÷ͻ״ϸ°û£¨cDC1£©ºÍ¹Å°åIIÐÍÊ÷ͻ״ϸ°û£¨cDC2£©¡£
Fig. 2 Functionally specialized conventional and non-conventional dendritic cell subsets and related lineages.
cDC1
cDC1ÆðÔ´ÓÚCD34+ÔìѪ¸Éϸ°û£¬·Ö½âÀú³ÌÊÜ°üÀ¨×ÌÈÅËص÷ÀíÒò×Ó8 £¨IRF8£©ÔÚÄÚµÄת¼Òò×Ó×éºÏµÄµ÷Àí£»¾ßÓÐÆæÒìµÄCÐÍÄý¼¯ËØÊÜÌåCLEC9AºÍÇ÷»¯Òò×ÓXCR1µÄ±í´ïÌØÕ÷¡£cDC1ͨ³£±»³ÆΪ½»Ö¯³ÊµÝDCs£¬ÒòÆä¾ßÓн»Ö¯³ÊµÝ¿¹ÔµÄÄÜÁ¦£¬²¢Äܹ»ÒýÆðÖ×ÁöÃâÒß·´Ó¦¡£
Fig. 3 Illustration depicts the common signatures and shared signatures expressed by human and mouse conventional dendritic cell subset 1. The signature includes surface markers, transcription factors and major pattern recognition receptors. The signatures with * marks indicate tissue specific expression.
cDC2
cDC2ÊÇͨ¹ý¸ßˮƽ±í´ïMHC II¡¢CD11cºÍSIRPAÀ´Ê¶±ðµÄ¡£cDC2ÑÇȺÖ÷ÒªÒÀÀµÓÚIRF4ºÍZeb2½éµ¼µÄת¼µ÷¿Ø£¬¶øcdc1ÒÀÀµÓÚIRF8¡¢BATF3ºÍID2¡£cDC2ÊDZ£´æÓÚÈËÌå²î±ð×éÖ¯ºÍÆ÷¹ÙÖÐÖ÷ÒªµÄDCȺÌ壬ËüÃDZí´ïһϵÁÐTLRs£¬Äܹ»¶Ô´ÓºËÜÕËáµ½¶àÌǵÄÖÖÖÖΣÏÕÐźÅ×÷³ö·´Ó¦¡£ÓëÆäËûÎÈ̬DCÑÇȺÏà±È£¬ËüÃÇ»¹±í´ïÁ˸ßˮƽµÄNLRPsºÍÆäËûÑ×Ö¢Ïà¹ØÐźŷÖ×Ó£¬Åú×¢ËüÃǾßÓиÐÖª²î±ðΣÏÕÐźŵĹ¦Ð§¡£
Fig. 4 Illustration depicts the common signatures and shared signatures expressed by human and mouse conventional dendritic cell subset 2. The signature includes surface markers, transcription factors and major pattern recognition receptors. The signatures with * marks indicate tissue specific expression.
pDCs
µ±Óöµ½²¡¶¾Ñ¬È¾Ï¸°ûʱ£¬pDCs±»È·¶¨Îª±¬·¢×ÌÈÅËصÄϸ°ûÑÇȺ£¬ËüÃDZ¬·¢IÐÍ×ÌÈÅËغͼ¤»îЧӦϸ°ûµÄÄÜÁ¦ÔÚÆô¶¯¿¹²¡¶¾ÃâÒßÓ¦´ð·½Ãæ¾ßÓÐÒªº¦×÷Óá£pDCs¶ÔÐí¶àRNAºÍDNA²¡¶¾ÓÐÏìÓ¦£¬°üÀ¨VSVG, HCV, HAV, LCMV£¬µÇ¸ïÈȲ¡¶¾µÈ¡£
Fig. 5 Illustration depicts the common signatures and shared signatures expressed by human and mouse plasmacytoid dendritic cell. The signature includes surface markers, transcription factors and major pattern recognition receptors.
LCs
LCs×îÔçÓÚ19ÊÀ¼Í±»Paul Langerhans·¢Ã÷£¬Øʺó±»ÒÔΪÊÇDCϸ°ûµÄÒ»¸öÑÇϵ¡£ÀúÊ·ÉÏ£¬LCs±»ÒÔΪÊÇÊ÷ͻ״ϸ°û£¬ÓÉÓÚËüÃǾßÓе䷶µÄÊ÷ͻ״ϸ°ûǨáãµ½ÁÜͶºÏ¡¢³ÊµÝ¿¹ÔºÍ¼¤»îTϸ°ûµÄÌØÕ÷¡£LCsλÖÃÓÅÔ½£¬Î»ÓÚÍâ½çÇéÐεÄ×îÍⲿ£¬ÊÇÃâÒßϵͳµÄµÚÒ»µÀ·ÀµØ¡£
Fig. 6 Specialized functions of mouse classical dendritic cell subsets.
»ùÓÚÒÑÓÐÑо¿£¬ÈËÀàºÍСÊóDCÒѾ±»ÀÖÒòËسɲî±ð¹¦Ð§µÄÑÇȺ¡£¹¹½¨ÒÅ´«Ð¡ÊóÄ£×Ó£¬Í¨¹ý¼ì²âÍâò±ê¼ÇÎï²î±ð×éÖ¯µÄ±í´ïÇéÐΣ¬ÓÐÖúÓÚ¹¦Ð§ÈßÓàµÄÑÇȺͳһ¡£Í¬ÑùµÄ£¬ÕâЩģ×ÓÓÐÖúÓÚÊèÉ¢¾ßÓзÇÈßÓ๦ЧµÄ±íÐÍÏàËƵÄÑÇȺ¡£¹ØÓÚÈËÀàDCµÄÑо¿£¬Ò²ÒѾÑØ×ÅÕâЩ˼Ð÷È¡µÃÁËÏ£Íû¡£
[1]Anderson D A , Dutertre C A , Ginhoux F , et al. Genetic models of human and mouse dendritic cell development and function[J]. Nature Reviews Immunology, 2020.
[2]Eisenbarth S C . Dendritic cell subsets in T cell programming: location dictates function[J]. Nature reviews. Immunology, 2018, 19(2).
[3]Balan S , Saxena M , Bhardwaj N . Dendritic cell subsets and locations[J]. International Review of Cell and Molecular Biology, 2019.
[4]Mueller,K. L . A dendritic cell target for immunotherapy[J]. Science, 2014, 346(6209):597-597.
[5]Steinman, Ralph M . Decisions About Dendritic Cells: Past, Present, and Future[J]. Annual Review of Immunology, 2012, 30(1):1-22.
[6]Broz M L , Binnewies M , Boldajipour B , et al. Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity[J]. Cancer Cell, 2014, 26(5):638-652.